Solid state characterization of pharmaceutical drug substances

Developing new small molecule pharmaceuticals is not an easy task! Once you have your candidate API, you must figure out how to produce this molecular structure as efficiently as possible, minimizing costs and maximizing yield at each step. Every process must be scalable and reproducible, whether you are making 5g or 5kg.

Our new webinar series, API Scale-up Strategies, explores how advanced tools for solid-state analysis can be applied to help improve process development and process optimization of small molecule drug substances. Join us as our characterization experts walk you through solutions to the challenges of scaling-up and show you the analytical tools that can de-risk your route to market.

We’ll examine the most common challenges and explore how applying the right analytical technologies at the right time can help you control:

• Particle size & particle shape
• Crystallization & polymorphism
• Chemical purity

We’ll also discuss how latest innovations from Malvern Panalytical can help you get on top of these challenges, making sure you can achieve reproducible results every time.

Who should attend? 

• Scientists working in pharmaceutical process development &optimization and manufacturing
• Chemists working on scale-up strategies 
• Anyone involved in method development at all stages of the pharmaceutical development pipeline

What will you learn? 

• Explore strategies to overcome the challenges of API scale-up 
• Learn about the complementary analytical tools that can help derisk process development of small molecule APIs
• Gain insight on particle size and shape analysis 
• Understand different approaches for assessing solid form / polymorphism
• Discover new ways of chemical purity validation